Ronald M. Nordmann
Präsident bei Global Health Associates LLC
Aktive Positionen von Ronald M. Nordmann
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Global Health Associates LLC | Präsident | 01.10.2000 | - |
The Johns Hopkins University | Direktor/Vorstandsmitglied | - | - |
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Direktor/Vorstandsmitglied | 01.09.2013 | - |
American Red Cross, Inc.
American Red Cross, Inc. Services to the Health IndustryHealth Services American Red Cross, Inc. provides individual and family social services. It is a humanitarian organization led by volunteers and guided by its Congressional Charter and the Fundamental Principles of the International Red Cross Movement, will provide relief to victims of disaster and help people prevent, prepare for, and respond to emergencies. The company was founded in 1881 and is headquartered in Kansas City, MO. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Ronald M. Nordmann
Ehemalige bekannte Positionen von Ronald M. Nordmann
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PAR PHARMACEUTICAL COMPANIES, INC. | Direktor/Vorstandsmitglied | 01.01.2001 | 28.09.2012 |
Independent Dir/Board Member | 01.01.2001 | 28.09.2012 | |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Direktor/Vorstandsmitglied | 23.12.1999 | 23.05.2008 |
BELLUS HEALTH | Direktor/Vorstandsmitglied | - | 18.08.2006 |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Direktor/Vorstandsmitglied | - | 03.10.2005 |
Deerfield Management Co. LP
Deerfield Management Co. LP Investment ManagersFinance Deerfield Management Co. LP (Deerfield) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Peter Drake in 1994. They are wholly owned by James E. Flynn and are controlled by its general partner, Flynn Management LLC. Deerfield provides discretionary investment management services in the healthcare sector to domestic and offshore private pooled investment vehicles and their related alternative investment vehicles. | Corporate Officer/Principal | 01.09.1994 | 01.01.2000 |
░░░ ░░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░ ░░░░░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Ronald M. Nordmann
Fairleigh Dickinson University | Masters Business Admin |
The Johns Hopkins University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 14 |
Vereinigtes Königreich | 2 |
Kanada | 2 |
Operativ
Director/Board Member | 8 |
Corporate Officer/Principal | 6 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 7 |
Finance | 4 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 14 |
---|---|
Endo Generics Holdings, Inc.
Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Roberts Pharmaceutical Corp.
Roberts Pharmaceutical Corp. Pharmaceuticals: OtherHealth Technology Roberts Pharmaceutical Corp. provides pharmaceutical products. It offers medicines for cardiovascular, gynecology. The company is headquartered in Eatontown, NJ. | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Deerfield Management Co. LP
Deerfield Management Co. LP Investment ManagersFinance Deerfield Management Co. LP (Deerfield) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Peter Drake in 1994. They are wholly owned by James E. Flynn and are controlled by its general partner, Flynn Management LLC. Deerfield provides discretionary investment management services in the healthcare sector to domestic and offshore private pooled investment vehicles and their related alternative investment vehicles. | Finance |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Finance |
BELLUS Health, Inc.
BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
Warner Chilcott Ltd.
Warner Chilcott Ltd. Pharmaceuticals: MajorHealth Technology Warner Chilcott Ltd. develops and provides pharmaceutical products. It focuses on the women’s healthcare and dermatology segment. The company was founded in 1996 and headquartered in Hamilton, Bermuda. | Health Technology |
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Health Technology |
PaineWebber, Inc. | Finance |
The Wall Street Journal, Inc.
The Wall Street Journal, Inc. Publishing: NewspapersConsumer Services The Wall Street Journal, Inc. publishes newspapers and periodicals. It covers international business, financial news, and issues of the United States. The company was established in 1889 and is headquartered in New York, NY. | Consumer Services |
Global Health Associates LLC | |
F. Eberstadt & Co., Inc. | |
American Red Cross, Inc.
American Red Cross, Inc. Services to the Health IndustryHealth Services American Red Cross, Inc. provides individual and family social services. It is a humanitarian organization led by volunteers and guided by its Congressional Charter and the Fundamental Principles of the International Red Cross Movement, will provide relief to victims of disaster and help people prevent, prepare for, and respond to emergencies. The company was founded in 1881 and is headquartered in Kansas City, MO. | Health Services |
- Börse
- Insiders
- Ronald M. Nordmann
- Erfahrung